Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controls [3]

Schizophrenia Research

Volumn 81, Issue 2-3, 2006, Pages 323-326

  Duncan, Erica ^a,b   Bollini, Annie M ^c   Sanfilipo, Michael ^d   Wieland, Susan ^d   Angrist, Burt ^d,e   Rotrosen, John ^d,e   Cooper, Thomas B ^e,f,g  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^g Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; HOMOVANILLIC ACID; NEUROLEPTIC AGENT;

AMINO ACID BLOOD LEVEL; CIRCADIAN RHYTHM; DOPAMINERGIC TRANSMISSION; GAS CHROMATOGRAPHY; HUMAN; LETTER; MASS SPECTROMETRY; NEUROTRANSMISSION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CIRCADIAN RHYTHM; FEMALE; HOMOVANILLIC ACID; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 30844461005     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2005.08.001     Document Type: Letter

References (11)

1. M. Davidson, and K.L. Davis A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls Arch. Gen. Psychiatry 45 1988 561 563
2. M. Davidson, M.F. Losonczy, R.C. Mohs, P. Powchick, L.B. Freed, R. Kaminsky, and K.L. Davis Methodologies for assessing central dopaminergic function: plasma and urinary homovanillic acid following debrisoquin administration Psychopharmacol. Bull. 23 1987 407 410
3. R. Davila, M. Zumarraga, I. Andia, and A.J. Friedhoff Persistence of cyclicity of the plasma dopamine metabolite homovanillic acid in neuroleptic treated schizophrenic patients Life Sci. 44 1989 1117 1121
4. A.R. Doran, D. Pickar, R. Labarca, P. Douillet, O.M. Wolkowitz, J.W. Thomas, A. Roy, and S.M. Paul Evidence for a daily rhythm of plasma HVA in normal controls but not in schizophrenic patients Psychopharmacol. Bull. 21 1985 694 697
5. A.R. Doran, R. Labarca, O.M. Wolkowitz, A. Roy, P. Douillet, and D. Pickar Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia Arch. Gen. Psychiatry 47 1990 558 563
6. E. Duncan, A. Wolkin, B. Angrist, M. Sanfilipo, S. Wieland, T.B. Cooper, and J. Rotrosen Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics Biol. Psychiatry 34 1993 523 528
7. K.S. Kendler, R.C. Mohs, and K.L. Davis The effects of diet and physical activity on plasma homovanillic acid in normal human subjects Psychiatry Res. 8 1983 215 223
8. J.M. Ribeyre, P. Lesieur, O. Varoquaux, S. Dollfus, M. Pays, and M. Petit A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia Biol. Psychiatry 36 1994 230 236
9. D.A. Sack, S.P. James, A.R. Doran, M.A. Sherer, M. Linnoila, and T.A. Wehr The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions Arch. Gen. Psychiatry 45 1988 162 166
10. A.E. Stroe, F. Amin, A. Hashmi, D. Densmore, T. Kahn, and P.J. Knott Diurnal variation in plasma homovanillic acid: not a renal phenomenon Biol. Psychiatry 41 1997 621 623
11. C.L. Whelton, R.N. Gupta, J.M. Cleghorn, and S.R. Ballagh Influence of renal clearance on peripheral homovanillic acid measurements in healthy subjects and schizophrenic patients Schizophr. Res. 11 1993 33 40